Asia Pacific Stroke Management Market Analysis (2017-2023)

  • ID: 4456907
  • Report
  • Region: Asia, Asia Pacific
  • 90 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • ABBOTT
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb.
  • Cardinal Health
  • General Electric (GE)
  • GlaxoSmithKline plc
  • MORE
The Asia Pacific Stroke Management Market would witness market growth of 9.1% CAGR during the forecast period (2017 - 2023). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth.

Asia-Pacific is the region with tremendous market potential, due to rising prevalence of strokes, which is due to growing incidence of chronic diseases and use of tobacco. In addition, initiatives for the improvement of healthcare sector taken by the governments in the region, and growing interest of leading manufacturers in the emerging economies would offer growth opportunities in the regio.

Based on Type, the market report segments the market into Diagnostics and Therapeutics. Diagnostics type includes Computed Tomography Scan (CT Scan), Echocardiography Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, and Other Diagnostics. Therapeutics includes Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, and Antihypertensive. Based on Application, the market report segments the market into Ischemic Stroke and Haemorrhagic Stroke Based on Countries; the Stroke Management market segments the market into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the Stroke Management Market. Key companies profiled in the report include B. Braun Melsungen AG, Boston Scientific Corporation, Teleflex Inc., Cardinal Health, Medtronic Plc., General Electric (GE), Merck Sharp & Dohme Corp., ABBOTT, GlaxoSmithKline plc, and Bristol-Myers Squibb.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ABBOTT
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb.
  • Cardinal Health
  • General Electric (GE)
  • GlaxoSmithKline plc
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Stroke Management Market, by Type
1.4.2 Asia Pacific Stroke Management Market, by Application
1.4.3 Asia Pacific Stroke Management Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Stroke Management Market
3.1 Asia Pacific Stroke Management Market by Type
3.1.1 Asia Pacific Diagnostics Market by Country
3.1.2 Asia Pacific Diagnostics Market by Type
3.1.2.1 Asia Pacific Computed Tomography Scan (CT Scan) Market by Country
3.1.2.2 Asia Pacific Echocardiography Market by Country
3.1.2.3 Asia Pacific Magnetic Resonance Imaging (MRI) Market by Country
3.1.2.4 Asia Pacific Carotid Ultrasound Market by Country
3.1.2.5 Asia Pacific Cerebral Angiography Market by Country
3.1.2.6 Asia Pacific Electrocardiography Market by Country
3.1.2.7 Asia Pacific Other Diagnostics Market by Country
3.1.3 Asia Pacific Therapeutics Market by Country
3.1.4 Asia Pacific Therapeutics Market by Type
3.1.4.1 Asia Pacific Tissue Plasminogen Activator Systems Market by Country
3.1.4.2 Asia Pacific Anticoagulant Market by Country
3.1.4.3 Asia Pacific Antiplatelet Market by Country
3.1.4.4 Asia Pacific Antihypertensive Market by Country

Chapter 4. Asia Pacific Stroke Management Market by Application
4.1 Introduction
4.1.1 Asia Pacific Stroke Management for Ischemic Stroke Market by Country
4.1.2 Asia Pacific Stroke Management for Haemorrhagic Stroke Market by Country

Chapter 5. Asia Pacific Stroke Management Market by Country
5.1 Introduction
5.2 China Stroke Management Market
5.2.1 China Stroke Management Market by Type
5.2.1.1 China Diagnostics Market by Type
5.2.1.2 China Therapeutics Market by Type
5.2.2 China Stroke Management Market by Application
5.3 Japan Stroke Management Market
5.3.1 Japan Stroke Management Market by Type
5.3.1.1 Japan Diagnostics Market by Type
5.3.1.2 Japan Therapeutics Market by Type
5.3.2 Japan Stroke Management Market by Application
5.4 India Stroke Management Market
5.4.1 India Stroke Management Market by Type
5.4.1.1 India Diagnostics Market by Type
5.4.1.2 India Therapeutics Market by Type
5.4.2 India Stroke Management Market by Application
5.5 South Korea Stroke Management Market
5.5.1 South Korea Stroke Management Market by Type
5.5.1.1 South Korea Diagnostics Market by Type
5.5.1.2 South Korea Therapeutics Market by Type
5.5.2 South Korea Stroke Management Market by Application
5.6 Singapore Stroke Management Market
5.6.1 Singapore Stroke Management Market by Type
5.6.1.1 Singapore Diagnostics Market by Type
5.6.1.2 Singapore Therapeutics Market by Type
5.6.2 Singapore Stroke Management Market by Application
5.7 Malaysia Stroke Management Market
5.7.1 Malaysia Stroke Management Market by Type
5.7.1.1 Malaysia Diagnostics Market by Type
5.7.1.2 Malaysia Therapeutics Market by Type
5.7.2 Malaysia Stroke Management Market by Application
5.8 Rest of Asia Pacific Stroke Management Market
5.8.1 Rest of Asia Pacific Stroke Management Market by Type
5.8.1.1 Rest of Asia Pacific Diagnostics Market by Type
5.8.1.2 Rest of Asia Pacific Therapeutics Market by Type
5.8.2 Rest of Asia Pacific Stroke Management Market by Application

Chapter 6. Company Profiles
6.1 B. Braun Melsungen AG.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 Boston Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Teleflex Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental Analysis
6.3.4 Research & Development Expense
6.4 Cardinal Health
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.5 Medtronic Plc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 General Electric (GE)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Merck Sharp & Dohme Corp.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 ABBOTT
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.9 GlaxoSmithKline plc
6.9.1 Financial Analysis
6.9.2 Segmental and Regional Analysis
6.9.3 Research & Development Expense
6.1 Bristol-Myers Squibb
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Teleflex Inc.
  • Cardinal Health
  • Medtronic Plc.
  • General Electric (GE)
  • Merck Sharp & Dohme Corp.
  • ABBOTT
  • GlaxoSmithKline plc
  • Bristol-Myers Squibb.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll